中信建投医改混合C(007553)利润分配表
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
2024-12-31 |
| 收入 |
-24,297,404.85 |
284,449,800.69 |
236,502,460.66 |
-344,340,933.22 |
| 利息合计 |
103,500.28 |
341,015.96 |
206,651.08 |
348,534.34 |
| 其中:存款利息收入 |
103,500.28 |
341,015.96 |
206,651.08 |
348,534.34 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益合计 |
-98,438,940.18 |
65,970,357.52 |
-180,953,971.04 |
-147,071,246.50 |
| 其中:股票投资收益 |
-101,102,248.06 |
59,814,652.44 |
-186,341,800.71 |
-158,724,283.03 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
116,491.54 |
327,272.01 |
91,603.63 |
2,783,776.82 |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
2,546,816.34 |
5,828,433.07 |
5,296,226.04 |
8,869,259.71 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
73,693,025.25 |
217,213,324.72 |
416,891,950.17 |
-198,319,559.35 |
| 其他收入 |
345,009.80 |
925,102.49 |
357,830.45 |
701,338.29 |
| 费用 |
6,072,880.23 |
16,413,445.01 |
8,279,845.08 |
19,851,705.97 |
| 管理人报酬 |
4,289,610.00 |
11,621,631.33 |
5,840,118.14 |
14,010,227.34 |
| 基金托管费 |
857,922.07 |
2,324,326.22 |
1,168,023.62 |
2,802,045.42 |
| 销售服务费 |
838,796.24 |
2,293,287.46 |
1,170,363.47 |
2,835,227.05 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中:卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
86,463.46 |
174,200.00 |
101,339.85 |
204,200.00 |
| 利润总额 |
-30,370,285.08 |
268,036,355.68 |
228,222,615.58 |
-364,192,639.19 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年